Assessment of the At-Home Diagnostic Testing Global Markets 2023-2027- Leading Players are Abbott, Roche, Siemens & 23andMe

News provided by

Jul 07, 2023, 17:15 ET

DUBLIN, July 7, 2023 /PRNewswire/ -- The "At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests) 2023" report has been added to ResearchAndMarkets.com's offering.

The At-Home in vitro diagnostic (IVD) testing market is comprised of IVD tests that can be purchased at the local store or on the Internet where the patient gathers the specimen and results are displayed usually within minutes. Generally, these are lateral flow technology or dip stick methods.

Meanwhile, the global Home IVD testing market is a growing market with much potential. The Home Collection IVD testing market is comprised of testing kits that are obtained from the local pharmacy or internet and sent to the patient's home. The patient collects the specimen, puts it into a collection container and sends it to the laboratory for testing. Results are sent back to the patient and/or referring physician.

Detailed Market Estimates by Specialty

This report covers the At-Home and Home testing markets by segmenting them into several broad areas including:

Cholesterol
Drugs of Abuse
Fecal Occult Blood
Glucose/HbA1c including CGM
Infectious Disease

COVID-19 /+ Flu + RSV
HIV

Pregnancy and Fertility
Rapid Coagulation
Genetic (excluding ancestry genetic testing)

The report also breaks out the market by venue:

At-Home Test (Patient Gets Result At Home)
Home Collection Test (Sent to Lab for Results Later)

A Long-standing Trend That Has Seen Renewed Focus

At-Home IVD tests designed for home use are generally available in the form of strips, cassettes, dip cards and digital monitoring devices. The most widely used patient self-tests are for pregnancy and ovulation and glucose. Manufacturers anticipated consumer acceptance of tests for occult blood, cholesterol, HIV, coagulation/PT and H. pylori. Worldwide, these tests have had minimal appeal. The need for a blood sample has limited the use of self-tests for cholesterol. Tests such as H. pylori have just not yet captured the interest of consumers. Outside the United States, consumers will find OTC tests for a wider range of analytes including allergens, TSH, and FSH. The latest trend to overcome reticence for self-testing is direct to consumer marketing of lab tests in public venues such as malls and supermarkets and home testing kits via the Internet.

The forecasted market analysis for 2022-2027 was largely based on demographic trends, new developments, innovative technology and global expansion.

The growth of the Home IVD testing market is born out of a paradigm shift among consumers who are seeking greater control over their own healthcare. Since the 1980s, consumers have pushed for access to their laboratory tests, but it has been slow to evolve due to concerns that consumers may try to diagnose themselves without understanding how diagnoses information all fits together.

With the increased use of the Internet for medical information, consumers have become medical consumers not just patients. This has created a change in the doctor/patient relationship as individuals become more knowledgeable about their own health and want more control over their personal information and treatment decisions. Consumers are more cost-conscious and the increase in high-deductible insurance plans requires that individuals ask more questions, do their own research and collaborate with their doctor about medical decisions, tests, and treatments.

Drivers include the growing demand for early disease detection and diagnosis, personalized medicine, the importance of disease monitoring, expanded technologies and cost.

The precursor to the Home IVD testing market rests with the rise of genetic testing which began in the 1970s and has grown to include tests for cancer and other illnesses that there may be a genetic susceptibility in the family. Ancestral testing provided clues as to what may be in the ancestral pool prompting consumers to discover more about their own predisposition for certain diseases. The passage of the 2008 Genetic Information Nondiscrimination Act (GINA) has opened the door for consumer awareness of genetic make-up without the fear of discrimination by health insurers and employers.

Companies that provide such testing offer a broad range of services, such as predicting adverse reactions to specific medications, estimating susceptibility to various complex diseases, and diagnosing predominantly genetic disorders.

Several trends are continuing to shape the home laboratory testing market including the growing demand for early disease detection and diagnosis, personalized medicine, the importance of disease monitoring, expanded technologies and cost.

Key Topics Covered:

Chapter 1: Executive Summary

Industry at a Glance
Scope and Methodology
Size and Growth of the Market
Key Issues and Trends Affecting the Market
Competitive Outlook
Conclusion Highlights

Chapter 2: Introduction

Overview
Issues and Trends
COVID-19
Insurance for Home Tests
Home IVD Testing Drivers and Challenges
Genetics
Home Collection

Chapter 3: At-Home IVD Tests

Introduction
Diabetes
Pregnancy and Fertility
Infectious Disease
HIV
COVID-19
COVID-19 & Flu
Coagulation
Fecal Occult Blood
Cholesterol
Drugs of Abuse
At-Home IVD Test Market by Test Type
At-Home IVD Tests Market by Sample Type
Blood Samples
Urine Samples
Oral/Saliva Samples
Nasal Samples
Stool Samples
Other

Chapter 4: Home Collection IVD Tests

Introduction
Pregnancy and Fertility
Infectious Disease
HIV
HPV and other STDs
COVID-19
COVID-19 & Flu
Fecal Occult Blood
Cholesterol
Genetics
Home Collection IVD Tests by Test Type
Privacy
Home Collection Tests by Sample Type
Blood Samples
Urine Samples
Oral/Saliva Samples
Nasal Samples
Stool Samples
Other

Chapter 5: Market Participants

23andMe, Inc
Abbott Diagnostics
AccessBio, Inc.
ACON Laboratories, Inc.
ARKRAY, Inc.
Ascensia Diabetes Care Holdings AG
Atomo Diagnostics
Becton-Dickinson
binx health
Biomerica, Inc.
Biosynex SA
BTNX Inc.
Church & Dwight Co. Inc
Color Health, Inc.
Cue Health
Dexcom, Inc.
EasyDNA
Everlywell
Exact Sciences
First Check Diagnostics LLC
GlysBy diagnostics
Helena Laboratories
Hemosure, Inc.
LifeScan, Inc
Medichecks.com Ltd.
Myriad Genetics, Inc.
OraSure Technologies, Inc.
Polymedco, Inc
Preventis GmbH
Prima Lab SA
QuidelOrtho Corporation
Roche Diagnostic Corporation
Siemens Healthineers GmbH
Swiss Precision Diagnostics GmbH
Trividia Health
VedaLab

Chapter 6: Market Analysis

Market Overview
Market Segment by Test Type
Glucose & HbA1c
Infectious Disease
Other Areas
Genetic
Market by Distribution
Market by Region

For more information about this report visit https://www.researchandmarkets.com/r/nyee77

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets